Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Huperzine A
2. Huperzine A, (5alpha,9beta,11z)-(-)-isomer
3. Fordine
1. Huperzine A
2. 120786-18-7
3. ( Inverted Exclamation Marka)-huperzine A
4. Fordine
5. Huperizine A
6. (-)-huperzine A
7. (+)-huperzine A
8. (-)-huperzine A (hupa)
9. Huperzinea
10. Ncgc00159362-02
11. 102518-79-6
12. (?)-huperazine A
13. Schembl679315
14. Chembl394259
15. Schembl1047469
16. Chebi:91724
17. Huperzine A [(-)-huperzine A]
18. Dtxsid801115670
19. Hms1362i05
20. Hms1792i05
21. Hms3403i05
22. 103735-86-0
23. Akos022661860
24. Akos026750633
25. Cs-1089
26. Ncgc00163246-02
27. Ncgc00163246-03
28. 5,9-methanocycloocta(b)pyridin-2(1h)-one, 5-amino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-
29. As-75811
30. Hy-17388
31. (+/-)-huperzine A, Synthetic, >=98% (tlc)
32. Brd-a47065382-001-02-9
33. (11e)-5-amino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-5,9-methanocycloocta[b]pyridin-2(1h)-one
34. (13e)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.0^{2,7}]trideca-2(7),3,5,10-tetraen-5-ol
35. (afae'a Centa' Nota Inverted Exclamation Markafasa'a Inverted Exclamation Markafae'adaggeratrade Markafa Centa Centa' Nota Inverted Exclamation Marka'a Not)-huperzine A
Molecular Weight | 242.32 g/mol |
---|---|
Molecular Formula | C15H18N2O |
XLogP3 | 0 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 0 |
Exact Mass | 242.141913202 g/mol |
Monoisotopic Mass | 242.141913202 g/mol |
Topological Polar Surface Area | 55.1 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 551 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Cholinesterase Inhibitors
Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)
Neuroprotective Agents
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)
Market Place
ABOUT THIS PAGE
A Fordine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fordine, including repackagers and relabelers. The FDA regulates Fordine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fordine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fordine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fordine supplier is an individual or a company that provides Fordine active pharmaceutical ingredient (API) or Fordine finished formulations upon request. The Fordine suppliers may include Fordine API manufacturers, exporters, distributors and traders.
click here to find a list of Fordine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fordine DMF (Drug Master File) is a document detailing the whole manufacturing process of Fordine active pharmaceutical ingredient (API) in detail. Different forms of Fordine DMFs exist exist since differing nations have different regulations, such as Fordine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fordine DMF submitted to regulatory agencies in the US is known as a USDMF. Fordine USDMF includes data on Fordine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fordine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fordine suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fordine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fordine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fordine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fordine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fordine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fordine suppliers with NDC on PharmaCompass.
Fordine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fordine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fordine GMP manufacturer or Fordine GMP API supplier for your needs.
A Fordine CoA (Certificate of Analysis) is a formal document that attests to Fordine's compliance with Fordine specifications and serves as a tool for batch-level quality control.
Fordine CoA mostly includes findings from lab analyses of a specific batch. For each Fordine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fordine may be tested according to a variety of international standards, such as European Pharmacopoeia (Fordine EP), Fordine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fordine USP).
LOOKING FOR A SUPPLIER?